Efficient pre-screening process with over 6,800 pre-screenings conducted each year
Over 50% of hyperCORE sites have access to FibroScan® technology
Database with over 330,000 high-risk patients
Over 200,000 Latino and South Asians in patient databases with high-NASH incidence
Access to liver biopsies, specialized MRI-PDFF and MRE
Partner Highlights
FOMAT Medical Research has access to over 60 gastroenterologists, on-site DEXA & FibroScan imaging, along with a 3rd party mobile vendor for imaging.
Centricity Research has on-site DEXA & FibroScan imaging at multiple locations in the United States and Canada, access to over 100 gastroenterologists and endocrinologists, and is presently conducting a Canadian NASH registry trial.
MOORE Clinical Research has access to a large Latino population in the Tampa area to target with NASH trials.
QCR Clinical Research has a FibroScan and access to large Latino and Native American populations.
True Blue Clinical Research has access to a large Latino population in the Tampa area to target NASH trials.